PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
48 hedge funds and large institutions have $42.2M invested in Provention Bio, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 14 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
63% less call options, than puts
Call options by funds: $164K | Put options by funds: $447K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
48
Holding in Top 10
–
Calls
$164K
Puts
$447K
Top Buyers
1 | +$4.95M | |
2 | +$4.95M | |
3 | +$4.55M | |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.08M |
5 |
MS
Maven Securities
St Helier,
Jersey
|
+$1.7M |
Top Sellers
1 | -$891K | |
2 | -$467K | |
3 | -$394K | |
4 |
EI
EAM Investors
Solana Beach,
California
|
-$303K |
5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$282K |